Innovision IPO Day 3 Sees Muted Demand, Subscription At 12%

The IPO, which opened on March 10 and closes today, has seen modest demand across investor categories. Retail participation remains subdued, while institutional interest has been limited. The muted response highlights cautious sentiment in the broader market environment.

Grey Market Premium Trends
The GMP for Innovision IPO is currently around ₹13, suggesting limited listing gains. Market watchers note that the premium has remained weak throughout the bidding period, reflecting skepticism about near-term performance.

Brokerage Review
Brokerages such as Swastika Investmart have advised avoiding the IPO, citing stretched valuations and thin operating margins. While Innovision operates in manpower services, analysts believe the company’s fundamentals do not justify aggressive pricing, especially in a volatile market.

Investor Outlook
Experts suggest that investors should weigh the risks carefully before applying. With muted subscription levels and a weak GMP, the IPO may not deliver strong listing gains. Long-term prospects depend on execution and demand recovery in the manpower services sector.

Key Highlights

• Innovision IPO size: ₹323 crore
• Subscription status: 12% on Day 3
• Price band: ₹521–₹548 per share
• GMP around ₹13, signaling weak listing gains
• Brokerages advise caution due to high valuation

Sources: The Economic Times, Mint, Univest